Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04564599 · ClinicalTrials.gov registry record
The Rise of Ride Sharing Companies and Trends in Impaired Driving Accidents
A clinical trial, sponsored by Methodist Health System.
- Terminated
- Registry status
- 100
- Enrollment target
NCT04564599: Clinical Trial study, sponsored by Methodist Health System.
NCT04564599 is a clinical trial that was terminated before completion, run by Methodist Health System. The registered enrollment target is 100 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04564599 was terminated before completion, sponsored by Methodist Health System.
- TERMINATED
- Registry status
- 100 participants
- Enrollment target
Study Summary
This will be a retrospective study with data collected from the trauma registry. We plan to complete the data collection and analysis by 12/31/2020. Data on ride sharing will be obtained from the Uber and Lyft websites. Data pertaining to number of alcohol- and drug-related motor vehicle (and auto-ped) collisions will be obtained from the Texas Department of Transportation website, the National Highway Traffic Safety Administration, the Shared-Use Mobility Center (SUMC) and the Transformation of Public Transit, the Texas A\&M Transportation Institute, Texas Department of Public Safety, and the U.S. Department of Transportation website (or equivalent). Sexual assault data will be obtained as available the Sexual Assault Nurse Examiner (SANE) database as well as from Turning Point Rape Crisis Center and surrounding hospitals in the Dallas area as well as the Uber report for sexual assaults.
Primary Outcome
Results of alcohol screen and drug screens
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2023-07-06 |
| Est. Completion | 2025-06-06 |
Why NCT04564599 stopped before completion
NCT04564599 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT04564599 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04564599 about?
NCT04564599 is a clinical study titled "The Rise of Ride Sharing Companies and Trends in Impaired Driving Accidents". This will be a retrospective study with data collected from the trauma registry. We plan to complete the data collection and analysis by 12/31/2020. Data on ride sharing will be obtained from the Uber and Lyft websites. Data pertaining to number of alcohol- and drug-related motor vehicle (and auto-p...
What is the current status of trial NCT04564599?
This trial is currently terminated. The enrollment target is 100 participants. The study started on 2023-07-06. Estimated completion is 2025-06-06.
Who is sponsoring clinical trial NCT04564599?
This trial is sponsored by Methodist Health System, which has 125 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI